Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009.

Hanna JN, Humphreys JL, Murphy DM, Smith HV.

Med J Aust. 2010 Oct 4;193(7):392-6.

PMID:
20919968
2.

Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005-2007.

Hanna JN, Humphreys JL, Murphy DM.

Med J Aust. 2008 Jul 7;189(1):43-6.

PMID:
18601643
3.

Invasive pneumococcal disease in Indigenous people in north Queensland, 1999-2004.

Hanna JN, Humphreys JL, Murphy DM.

Med J Aust. 2006 Feb 6;184(3):118-21.

PMID:
16460296
4.

The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.

Lehmann D, Willis J, Moore HC, Giele C, Murphy D, Keil AD, Harrison C, Bayley K, Watson M, Richmond P.

Clin Infect Dis. 2010 Jun 1;50(11):1477-86. doi: 10.1086/652440.

PMID:
20420501
5.

Pneumococcal disease in South Australia: vaccine success but no time for complacency.

Johnson DR, D'Onise K, Holland RA, Raupach JC, Koehler AP.

Vaccine. 2012 Mar 9;30(12):2206-11. doi: 10.1016/j.vaccine.2011.12.119. Epub 2012 Jan 23.

PMID:
22273663
6.

Invasive pneumococcal disease in the Northern Territory of Australia, 1994-1998.

Krause VL, Reid SJ, Merianos A.

Med J Aust. 2000 Oct 2;173 Suppl:S27-31. Erratum in: Med J Aust 2001 Mar 19;174(6):309.

PMID:
11062803
8.

Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.

Jayasinghe S, Chiu C, Menzies R, Lehmann D, Cook H, Giele C, Krause V, McIntyre P.

Vaccine. 2015 Nov 27;33(48):6666-74. doi: 10.1016/j.vaccine.2015.10.089. Epub 2015 Oct 29.

PMID:
26519550
9.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
10.

The epidemiology of invasive pneumococcal disease in children in Far North Queensland.

Fagan RL, Hanna JN, Messer RD, Brookes DL, Murphy DM.

J Paediatr Child Health. 2001 Dec;37(6):571-5.

PMID:
11903838
11.

Invasive pneumococcal disease in Australia, 2006.

Roche PW, Krause V, Cook H, Barralet J, Coleman D, Sweeny A, Fielding J, Giele C, Gilmour R, Holland R, Kampen R; Enhanced Invasive Pneumococcal Disease Surveillance Working Group, Brown M, Gilbert L, Hogg G, Murphy D; Pneumococcal Working Party of the Communicable Diseases Network Australia.

Commun Dis Intell Q Rep. 2008 Mar;32(1):18-30.

12.

High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D.

PLoS One. 2013 Dec 3;8(12):e82280. doi: 10.1371/journal.pone.0082280. eCollection 2013.

13.

Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.

Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.

Clin Infect Dis. 2010 May 1;50(9):1238-46. doi: 10.1086/651680.

PMID:
20367225
15.

[Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].

Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):14-21. doi: 10.1016/j.eimc.2008.03.001. Epub 2009 Jan 9. Spanish.

PMID:
19217998
16.

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.

17.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.

PMID:
17583392
18.

Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.

Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, Grau I, Martín R, Liñares J.

Clin Infect Dis. 2009 Jan 1;48(1):57-64. doi: 10.1086/594125.

PMID:
19035779
19.

Invasive pneumococcal disease in Australia 2007 and 2008.

Barry C, Krause VL, Cook HM, Menzies RI.

Commun Dis Intell Q Rep. 2012 Jun 30;36(2):E151-65.

20.

Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.

Salleras L, Domínguez A, Ciruela P, Izquierdo C, Navas E, Torner N, Borras E.

Clin Microbiol Infect. 2009 Nov;15(11):997-1001. doi: 10.1111/j.1469-0691.2009.02938.x. Epub 2009 Aug 18.

Supplemental Content

Support Center